RECRUITING

Non-invasive Treatment for Long COVID (Post COVID-19 Condition) Brain Fog

Talk to us

Conditions

Long COVIDbrain fogbrain blood flowheart rate variabilityfatigue

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study aims to assess the effects of both acute and chronic exposures to hypoxia and hypercapnia in patients with Long COVID syndrome.

Official Title

Pilot Study to Investigate Possible Non-invasive Treatment for Long COVID (Post COVID-19 Condition) Brain Fog

Quick Facts

Study Start:2024-09-24
Study Completion:2025-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06614309

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * English speaking
  2. * Diagnosis of Long COVID
  1. * Any history of:
  2. * Coronary artery dissection or aortic dissection
  3. * Neurological disease (e.g. dementia, Alzheimer's disease, or other brain-related disease)
  4. * Cerebrovascular disease or stroke
  5. * Aneurysm
  6. * If currently has:
  7. * Moderate-severe chronic obstructive pulmonary disease
  8. * Uncontrolled moderate-severe asthma
  9. * Moderate-severe bronchiectasis
  10. * Moderate-severe interstitial lung disease, requiring the use of supplemental oxygen
  11. * A necessity to use supplemental oxygen, for any reason
  12. * New or worsening symptoms (decompensation) of heart failure
  13. * Right heart disease due to chronic pulmonary disease/sleep apnea
  14. * Uncontrolled myocardial ischemia or angina
  15. * Uncontrolled heart arrhythmias
  16. * Heart or lung infection (e.g. myocarditis or pericarditis)
  17. * Left main coronary artery stenosis
  18. * Moderate-severe aortic stenosis
  19. * Pulmonary embolism, pulmonary infarction, or other blood clots
  20. * Severe respiratory disease
  21. * Chronic kidney disease
  22. * Chronic liver disease
  23. * Females of childbearing potential will complete a urine pregnancy test at their baseline visit to rule out pregnancy
  24. * BMI \>40
  25. * Study staff unable to obtain adequate signal for cerebral blood flow

Contacts and Locations

Study Contact

Parks
CONTACT
480-31-6616
parks.jrdan@mayo.edu

Principal Investigator

Courtney Wheatley-Guy
PRINCIPAL_INVESTIGATOR
Mayo Clinic

Study Locations (Sites)

Mayo Clinic in Arizona
Scottsdale, Arizona, 85259
United States

Collaborators and Investigators

Sponsor: Mayo Clinic

  • Courtney Wheatley-Guy, PRINCIPAL_INVESTIGATOR, Mayo Clinic

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-09-24
Study Completion Date2025-12

Study Record Updates

Study Start Date2024-09-24
Study Completion Date2025-12

Terms related to this study

Keywords Provided by Researchers

  • brain fog
  • brain blood flow
  • heart rate variability
  • fatigue

Additional Relevant MeSH Terms

  • Long COVID